Digoxin Tablets recall: Contamination
Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake Drive, East Windsor, New Jersey…
Why was Digoxin Tablets recalled?
Cross Contamination with Other Products:(mycophenolate mofetil).
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: M23172A, Exp 01/31/2025
- Product
- Digoxin Tablets, USP 125mcg, (0.125 mg), 1000-count bottle, Rx Only, Manufactured by: Novitium Pharma LLC., 70 Lake Drive, East Windsor, New Jersey…
- Recalling firm
- Novitium Pharma LLC
- Quantity
- 3,940 1000-count bottles
- Distribution
- Nationwide in the USA
- Recall date
- March 27, 2024
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)